CGFNS International Reports Nurse Migration Rates to the U.S. Remained High in 2024
Uncertain outlook for 2025 as new immigration policies are implemented
PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / February 11, 2025 / A new CGFNS International report indicates that a robust annual rate of nurse migration into the United States held steady in 2024 as healthcare systems continued to look to foreign-educated nurses to help address persistent staffing shortages.CGFNS International 2024 Nurse Migration Report
However, in its 2024 Nurse Migration Report, the organization also said the current high rates were likely unsustainable amid persisting visa retrogression and caps on employment-based green cards for nurses, along with new immigration policies being implemented by the Trump Administration that will likely have further impact on visa availability and processing times.
CGFNS, a global health workforce non-profit that verifies credentials of healthcare professionals for immigration authorities and state licensing boards, reported that in fiscal year 2024 it received 24,733 applications for its VisaScreen® (VS) service. While this is a 4.6% drop from FY 2023, the organization noted application levels remain significantly higher than pre-pandemic figures, with the 2024 figure at nearly 200% above FY 2018.
Other key data from the report:
While VS certifications went to nurses from more than 100 countries in 2024, 92% were educated in one of the top 10 countries on the list.
The Philippines continued to account for more than 51% of VS certificates, followed by Canada with 8% and Kenya with 6.5%. There has been a slight shift in this distribution recently, with the Philippines dropping from 60% of the total last year, while Kenya, Nigeria, and Ghana have all showed considerable growth in their share.
Like countries of education, visa categories are also significantly concentrated, with 76% of VS certificates issued to those seeking permanent green cards (such as EB-3 visas), while TN (12%) and H1-B (11%) made up the only other significant categories.
"These figures confirm what others are seeing, that U.S. healthcare systems continue to depend on nurse immigrants to address persistent staffing shortages. Disruptions to this pipeline of qualified nurses would have far-reaching consequences, exacerbating workforce shortages, increasing patient care loads, and worsening nurse burnout," said Dr. Peter Preziosi, President and CEO of CGFNS. "This is a multilayered global challenge that demands collaborative and innovative solutions among source and receiving countries."
CGFNS International is approved by the U.S. Department of Homeland Security to satisfy federal credential screening requirements for occupational visas for nine categories of foreign-educated healthcare professionals.
To offer global context for the U.S. numbers, the report also analyzes worldwide migration of nurses and healthcare professionals, particularly as both source and destination countries continue to grapple with balancing the demand for skilled healthcare workers against the challenges of retaining their domestic workforces. It noted that some countries in Africa, including Zimbabwe and Ghana, have paused the release of certificates that are needed by nurses to emigrate, while Nigeria has introduced in-country service requirements that nurses must fulfill prior to migration. Other governments, such as Namibia, have pursued the pathway of creating incentives for nurses who choose to stay.
Download the 2024 Nurse Migration Report: Balancing sustained workforce demand amid shifting migration flows.
Contact Information
David St. John
dstjohn@cgfns.org
SOURCE: CGFNS International
View the original press release on ACCESS Newswire
CGFNS International

Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
BioFi's Phēnix X Family Expands: Revolutionary Phēnix XT, (Phēnix X Tablet), Enters CE Testing Phase, Paving the Way for Global Launch28.4.2025 11:00:00 CEST | Press release
WELDON SPRING, MO / ACCESS Newswire / April 28, 2025 / Finnovant Inc., a leading innovator in biometric authentication and blockchain solutions, is proud to announce a new and innovative Tablet. the Phēnix XT, the latest addition to the groundbreaking Phēnix Family of devices, has completed countrywide evaluations, and has officially entered the CE testing phase. This critical step is anticipated to be completed by June 15, 2025, moving the Phēnix XT closer to global availability. The introduction of the Phēnix XT marks an amazing new development for the Phēnix X platform, opening up a huge opportunity globally, particularly for numerous educational and business applications. Designed to complement the Phēnix X phone and platform, the tablet brings a larger form factor and enhanced capabilities to the secure, decentralized ecosystem. Following successful CE Certification, the Phēnix XT Tablet will be submitted for Type Approval testing in all countries where the Phēnix X phone has alre
BioFi's Revolutionary Phēnix X Blockchain Phone Achieves 4G Type Approval and Certification, Paving the Way for Nigerian Launch28.4.2025 10:00:00 CEST | Press release
WELDON SPRING, MO / ACCESS Newswire / April 28, 2025 / Finnovant Inc., a trailblazing fintech company specializing in mobile technology and biometric authentication solutions, proudly announces that its revolutionary Phēnix X Blockchain phone has successfully attained the coveted 4G Type Approval certification in Nigeria. This significant milestone ensures seamless compatibility with mobile networks across Nigeria and paves the way for launches in other markets across Africa, Southeast Asia, and South America. The BioFi team is thrilled by this achievement as it prepares for the impending launch in the Nigerian market, on the heels of the Nigerian Communications Commissions (NCC) Approvals. The Phēnix X is poised to revolutionize user experiences in Nigeria and other markets, offering advanced security, deep blockchain integration, immersive training capabilities, integrated partner content, and cutting-edge technological advancements. As a leading advocate and pioneer in mobile Blockc
Finnovant Inc. and Storage Chain Announce Industry-First PhenixLoc Data Manager Launch, Bringing Unprecedented Security and Innovative Features with Affordable Decentralized Storage to Emerging Markets28.4.2025 09:00:00 CEST | Press release
MOUNTAIN VIEW, CA / ACCESS Newswire / April 28, 2025 / Finnovant, a leader in mobile technology and biometric authentication solutions, and Storage Chain, a pioneer in decentralized storage technology, today announced the upcoming launch of the PhēnixLoc Data Manager, set for June 1, 2025. This groundbreaking product utilizing Web 3 technology is poised to revolutionize data security and accessibility, particularly for underbanked and unbanked individuals in emerging markets, offering an industry-first combination of advanced security, user control, and affordability on Android, iOS, and through Browsers on any device. The PhēnixLoc Data Manager provides encrypted, decentralized storage for all types of private or sensitive information. Built with the specific needs of emerging markets in mind, it delivers incredible security and pricing designed to be accessible and affordable for anyone. Access to PhēnixLoc is through Web 3 decentralized technology and secured by Say-Tec, Finnovant's
Progressive Supranuclear Palsy Phase 2 Platform Clinical Trial Announces the Selection of AADvac1 and AZP2006 for its First Two Regimens28.4.2025 08:00:00 CEST | Press release
LONDON, GB / ACCESS Newswire / April 28, 2025 / The Progressive Supranuclear Palsy (PSP) Trial Platform (PTP), led by Drs. Adam Boxer (University of California, San Francisco [UCSF]), Irene Litvan (University of California, San Diego), Julio Rojas (UCSF) and Anne-Marie Wills (Massachusetts General Hospital), has selected two promising drug candidates-Axon Neuroscience's AADvac1 and Alzprotect's AZP2006-for inclusion in the platform trial as the first two compounds to be evaluated. The trial aims to accelerate the development of effective treatments for PSP, a rare and fatal neurodegenerative disease. Additional compounds to be evaluated in the trial are expected to be announced later this year. Funded by the National Institute on Aging (NIA), part of the U.S. National Institutes of Health (NIH), the platform trial is supported by a five-year grant. Its design enables multiple therapies to be tested concurrently, establishing a perpetual, efficient and flexible path to evaluate promisin
SYNLawn Welcomes Romania’s First Official SYNLawn Distributor27.4.2025 04:00:00 CEST | Press release
POPEŞTI-LEORDENI, RO / ACCESS Newswire / April 27, 2025 / SYNLawn, a global manufacturer and innovator of bio-based synthetic turf, announced its expansion into a new international market with the launch SYNLawn Romania. The company will carry SYNLawn's premium line of synthetic turf and surfacing products as the first official and exclusive distributor in Romania. "Our newest official partner is dedicated to bringing premium artificial turf solutions to the Romanian market," said George Neagle, president of SYNLawn Global. "With a strong focus on landscaping, golf, and commercial applications, SYNLawn Romania is set to redefine outdoor spaces in its region with high-quality, durable, and environmentally friendly artificial grass." The company started its business in 2022 and is based in Popești-Leordeni, just 9 kilometers from Bucharest. SYNLawn Romania specializes in the distribution of premium landscaping products. While new to the artificial turf sector, the company has a solid fou
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom